Godkännande för att inleda kliniska fas I/II-studier för COVID-19-vaccinet utvecklat av Prof. Salanti

Share this post

We use cookies to improve the functionality, performance, and effectiveness of our website. Detailed information on the use of cookies is provided in our Privacy Policy and Terms of Use. By continuing to use this site, or by clicking “I agree” you consent to the use of cookies.